Twitter | Pretraživanje | |
Jim Greenwood
During at , I discussed BIO's commitment to capping out-of-pocket costs for patients in Part D. The truth is, short-sighed policies currently in front of Congress will stifle innovation and do little to help seniors better afford the medicines they need.
Reply Retweet Označi sa "sviđa mi se" More